The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
eFFECTOR Therapeutics, Inc. Common Stock 28202V108 1,456 1,025,697 SH   SOLE   1,025,697 0 0
Evolv Technologies Holdings, Inc. Common Stock 30049H102 4,210 1,582,721 SH   SOLE   1,582,721 0 0
PMV Pharmaceuticals, Inc. Common Stock 69353Y103 14,097 989,232 SH   SOLE   989,232 0 0
Cyteir Therapeutics, Inc. Common Stock 23284P103 7,399 2,474,572 SH   SOLE   2,474,572 0 0
Homology Medicines, Inc. Common Stock 438083107 126 64,000 SH   SOLE   64,000 0 0
Precision BioSciences, Inc. Common Stock 74019P108 1,798 1,123,913 SH   SOLE   1,123,913 0 0
ionQ, Inc. Common Stock 46222L108 6,034 1,377,597 SH   SOLE   1,377,597 0 0
Selecta Biosciences, Inc. Common Stock 816212104 1,130 862,543 SH   SOLE   862,543 0 0
Spero Therapeutics, Inc. Common Stock 84833T103 185 249,070 SH   SOLE   249,070 0 0
Centessa Pharmaceuticals plc Sponsored ADS 152309100 14,306 2,937,615 SH   SOLE   2,937,615 0 0
Aerovate Therapeutics Inc. Common Stock 008064107 9,437 603,762 SH   SOLE   603,762 0 0
DICE Therapeutics Inc. Common Stock 23345J104 8,329 536,693 SH   SOLE   536,693 0 0
Graphite Bio Common Stock 38870X104 1,117 406,308 SH   SOLE   406,308 0 0
Landos Biopharma, Inc. Common Stock 515069102 1,174 1,612,764 SH   SOLE   1,612,764 0 0
Vor Biopharma Inc. Common Stock 929033108 1,862 374,714 SH   SOLE   374,714 0 0